Introductory Report
A summary of all your DNA health reports, covering disease risks, functional health, and performance.
Download sample report ›
DNA Intelligence
Your genetic blueprint, decoded.
EVA™ screens more than 200 million genetic variants through OmicsEdge and delivers 14 reports across five categories, from methylation and detox pathways to inherited cancer and medication response.
The reports
Fourteen reports. One clear picture.
What your DNA reveals, and how EVA™ acts on it.
Methylation pathway
Reads eight genes controlling folate conversion, B12 absorption, homocysteine recycling and neurotransmitter clearance.
EVA™ action. Targets impaired genes with L-Methylfolate, active B12, Magnesium, Omega-3 and Vitamin C.
Download sample report ›Detox pathway
Assesses Phase I and Phase II liver detoxification, how efficiently you process toxins, medications and waste.
EVA™ action. Supports detox capacity through targeted micronutrient protocols.
Download sample report ›Brain health
Evaluates cognitive resilience and Alzheimer's risk, including full ApoE genotyping with clear risk tiers.
EVA™ action. Supports brain health using Omega-3 DHA, metabolic optimisation and cognitive monitoring.
Download sample report ›Cardiovascular health
Weighs inherited risk for coronary artery disease and stroke against more than a million variants each.
EVA™ action. Optimises ApoB, inflammation and blood pressure targets to your genetic risk tier.
Download sample report ›Metabolic health
Examines predispositions to insulin resistance, Type 2 diabetes and energy-metabolism efficiency.
EVA™ action. Supports glucose and insulin optimisation using Berberine, Magnesium and dietary structure.
Download sample report ›Gut Health
Examines genetic predispositions affecting digestive function, gut lining integrity, and sensitivity to specific foods and compounds.
EVA™ action. Where relevant variants are identified, EVA™ targets gut lining support through Zinc and Magnesium, and flags dietary triggers for elimination.
Download sample report ›Hormone Health
Assesses genetic variants influencing testosterone pathways, oestrogen metabolism, cortisol regulation, and overall hormonal balance.
EVA™ action. Where variants are identified, EVA™ supports hormonal foundations using Zinc, Magnesium, and Vitamin D. Significant findings are flagged for physician review.
Download sample report ›Inflammation & Autoimmunity
Evaluates inherited tendencies toward elevated inflammatory response and immune dysregulation across key pathways.
EVA™ action. Where elevated risk is identified, EVA™ targets inflammation reduction using Omega-3 and Vitamin C, alongside personalised dietary guidance.
Download sample report ›Diet & nutrition
Reads your genetic response to carbohydrates, fats and protein, plus sensitivity risk for lactose, gluten and more.
EVA™ action. Personalises macronutrient ratios and starts elimination protocols for identified sensitivities.
Download sample report ›Fitness
Examines muscle fibre type, VO2 max potential, recovery rate and injury susceptibility.
EVA™ action. Guides training type, recovery windows and targeted support for physical performance.
Download sample report ›Cancer summary
Aggregates inherited risk across colorectal, prostate, breast, ovarian, lung, melanoma and pancreatic cancers.
EVA™ action. Initiates targeted early screening recommendations and lifestyle protocols for elevated risks.
Download sample report ›Pharmacogenomics (PGx)
Predicts how you metabolise cardiovascular, psychiatric, pain and other drug classes, and your adverse-reaction risk.
EVA™ action. Informs your EVA™ physician for medication and dosage guidance.
Download sample report ›Ancestry
Maps your genetic heritage across global populations, providing context for your inherited background.
Download sample report › Methylation pathway
23 genes, one core pathway.
Methylation underpins DNA repair, detoxification, neurotransmitter synthesis and homocysteine control. Each gene is reported as normal, slightly impaired, or significantly impaired.
23 genes comprehensively analysed. The 8 most impactful genes directly shape your protocol.
MTHFRMethylation
Converts folate into its active form for DNA repair and homocysteine recycling. The most clinically significant methylation gene, with variants in roughly 40% of people.
EVA™ action. L-Methylfolate with Vitamin B12.
FOLH1Methylation
Regulates absorption of natural folate from food, so variants reduce dietary folate even on a folate-rich diet.
EVA™ action. L-Methylfolate supplementation.
DHFRMethylation
Converts synthetic folic acid into active folate inside cells. Variants mean standard folic acid is poorly used.
EVA™ action. Active folate in place of standard folic acid.
MTRMethylation
Recycles homocysteine back into methionine, a key control point for homocysteine levels.
EVA™ action. Vitamin B12 supplementation.
MTRRMethylation
Regenerates the active B12 that MTR needs, so variants stall the cycle even when B12 looks adequate.
EVA™ action. Vitamin B12, methylcobalamin preferred.
CUBNMethylation
Controls B12 absorption from the gut, so variants cause poor uptake regardless of intake.
EVA™ action. Vitamin B12, sublingual or injectable for severe variants.
PDXKMethylation
Activates Vitamin B6 into its functional form for homocysteine metabolism and neurotransmitter synthesis.
EVA™ action. Active B6 support via Magnesium and a B6 complex.
COMTMethylation
Controls the breakdown of dopamine, adrenaline and oestrogen, shaping the stress response and oestrogen exposure.
EVA™ action. Magnesium, Omega-3 and Vitamin C, dosed to your COMT activity.
ApoE genotype
Alzheimer's risk, stratified.
The Alzheimer's result in the Brain Health report is driven by your ApoE genotype. EVA™ shows your allele pair and applies one of four tiers. This is a measure of genetic predisposition, not a diagnosis.
E2/E2 or E2/E3Protective
One or two protective alleles. Associated with below-average Alzheimer's risk.
Below average risk. Standard brain-health protocol.
E3/E3Average
Most common genotype. No E4 allele.
Average risk. Standard brain-health protocol.
E3/E4One E4
One risk allele.
Slightly elevated risk. Enhanced monitoring and targeted protocol support.
E4/E4Two E4
Two risk alleles.
Significantly elevated risk. Enhanced protocol and physician consult included.
Polygenic risk scores
The most powerful genetic signal available.
Most genetic tests look at single genes. A polygenic risk score aggregates signals from hundreds of thousands of variants across your genome to calculate your true inherited risk for a specific disease. Far more accurate than any single-gene result. OmicsEdge is the only direct-to-consumer platform with clinically validated polygenic risk scores published in Nature, covering heart disease, Alzheimer's, diabetes, and seven cancer types. Your EVA™ protocol is built with these scores as a foundation.
Coronary artery disease
Type 2 diabetes
Alzheimer's disease
Stroke risk
Breast cancer
Prostate cancer
Colorectal cancer
Melanoma
Pancreatic cancer
Get started
Curious? Let’s talk.
Curious? Let’s talk.
Your journey starts now.
Join the EVA™ waitlist and be first when the app launches in Dubai.
Guided onboarding At-home visit PDPL secure
Limited cohort · Dubai
Reserve your place
No payment now. We'll be in touch with foundation-access details via WhatsApp, SMS, and email.
By joining, you agree to be contacted by Elite Vita about EVA™ early access via email, SMS, and WhatsApp. Your data is stored in the UAE under PDPL.
Form to be replaced with GHL embed on production. Field names and styling are GHL-compatible.
Questions
Frequently asked.
EVA™ screens more than 200 million genetic variants through OmicsEdge and delivers 14 reports across five categories.
Methylation and detox, disease risk (all health reports plus cancer risks across seven cancer types), diet and sensitivities, pharmacogenomics, and ancestry.
A simple cheek swab collected at your home or office in Dubai. DNA results are typically available in roughly four weeks.
It reports your ApoE genotype and places it in one of four tiers. E2 carriers are protective, E3/E3 is average, and E4 carriers are elevated. It is a measure of genetic predisposition, not a diagnosis.
The Pharmacogenomics report predicts how you metabolise common medications, and informs your EVA™ physician for medication and dosage discussions.
EVA™'s DNA analysis is powered by OmicsEdge. Their platform analyses over 200 million genetic variants and uses polygenic risk scores, published in Nature, covering heart disease, Alzheimer's, cancer, and more. Most consumer DNA tests look at single genes. Polygenic risk scores look at hundreds of thousands of variants simultaneously, making them far more accurate.
No. EVA™ supports informed health decisions and does not diagnose, treat, cure or prevent disease. For medical concerns, consult a qualified healthcare provider.